Search

everythinglearnresearchcommunity

for

Search:↓

Genetics and hormones cause hair loss; finasteride treats it safely.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Taking hormonal contraceptives can cause skin changes, including hair loss, due to the effects of synthetic sex hormones.

Androgenic steroids can slow down or stop the growth of certain skin fungi.

All types of Platelet-Rich Plasma (PRP) can treat hair loss, but homologous PRP works best due to its higher platelet count and growth factors from multiple donors.

Androgenic alopecia is mainly caused by DHT, and new treatments focus on hair regeneration and aging factors.

Finasteride may cause male infertility, stopping it can help.

The document concludes that managing PCOS involves lifestyle changes, medication, and monitoring for associated health risks.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

New genes linked to male pattern baldness were found on chromosome 20p11.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.

Melatonin vitamin C-based nanovesicles improved hair growth and reduced hair loss in androgenic alopecia patients.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Hair growth and shedding are linked and can be disrupted, causing a delay known as the hair eclipse phenomenon, which is common in certain hair conditions and could lead to new treatments.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Men with early-onset hair loss have more heart disease risk factors.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Two treatments for male pattern hair loss are minoxidil and finasteride, but they have side effects and may not satisfy everyone.

Left-handed men experience more sexual side effects from finasteride treatment.

Finasteride helps reduce heart enlargement in heart failure patients.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Combining light therapy with certain substances improves hair growth in people with hair loss.

Creators of YouTube 'bro-science' baldness videos are driven by a need to share and persuade, often emphasizing authenticity and community building, while navigating trust issues related to commercial ties.